SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Kip518 who wrote (1004)1/19/1999 10:31:00 PM
From: Victor Cassella  Respond to of 1605
 
This stock will go back down to 25 cents if they keep on with these earning reports. They need medical reinbursment real soon of this stock will be nothing...

sorry but I have been in this stock since 92 and I could have bough Yahoo for the same price I paid for this thing!



To: Kip518 who wrote (1004)1/20/1999 8:43:00 PM
From: Michael Yang  Read Replies (1) | Respond to of 1605
 
Note this:

......coverage for EECP treatment are essential to the commercial success of the Company. The Company expects publication of the multicenter clinical study and determination of positive coverage policies to occur during the course of the current fiscal year.

The "current fiscal year" ends 5.31.99.

They better get something done by then, or they will get their ass sued off.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News